ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå º¸°í¼­(2021-2031³â) : ¹üÀ§, ¼¼ºÐÈ­, µ¿Çâ, °æÀï ºÐ¼®
North America Medical Writing Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
»óǰÄÚµå : 1819735
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,450 £Ü 4,962,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 4,450 £Ü 6,400,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,450 £Ü 7,838,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀåÀº Å©°Ô ¼ºÀåÇÏ¿© 2023³â 13¾ï 3,339¸¸ ´Þ·¯¿¡¼­ 2031³â¿¡´Â 31¾ï 2,866¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ¼ºÀåÀº 2023³âºÎÅÍ 2031³â±îÁö CAGR 11.3%¿¡ ÇØ´çÇÕ´Ï´Ù.

ÁÖ¿ä ¿ä¾à ¹× ½ÃÀå ºÐ¼®

ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ºÐ¾ß´Â ±ÔÁ¦ ¿ä°Ç Áõ°¡, ÀÓ»ó½ÃÇè ¼ö Áõ°¡, Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷ÀÇ È®´ë µî ¸î °¡Áö ¿äÀÎÀÌ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ ½ÄǰÀǾ౹(FDA) µî ±ÔÁ¦ ±â°üÀÌ Á¤ÇÑ ¾ö°ÝÇÑ ±ÔÁ¤ Áؼö ±âÁصµ Á¤È®ÇÑ ÀÇ·á ¹®¼­ ÀÛ¼º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¸ÞµðÄà ¶óÀÌÆÃ ¾÷¹«ÀÇ ¾Æ¿ô¼Ò½Ì Æ®·»µåµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­ ºÐ¼®

ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀåÀº À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ¼¼ºÐÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

1. À¯Çüº° : ½ÃÀåÀº ÀÓ»ó ¹®¼­ ÀÛ¼º, ±ÔÁ¦ ¹®¼­ ÀÛ¼º, °úÇÐÀû ¹®¼­ ÀÛ¼ºÀ¸·Î ³ª´¹´Ï´Ù. 2023³â¿¡´Â ÀÓ»ó½ÃÇè ¹× ÀǾàǰ Çã°¡ ½Åû¼­ ¹®¼­È­¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ÀÓ»ó ¹®¼­ ÀÛ¼ºÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

2. ¿ëµµº° : ¸ÞµðÄà ¶óÀÌÆÃÀÇ ¿ëµµ¿¡´Â ÀÇÇÐ Àú³Î¸®Áò, ÀÇÇÐ ±³À°, ¸ÞµðÄà ¸¶ÄÉÆÃÀÌ Æ÷ÇԵ˴ϴÙ. 2023³â¿¡´Â ÀÇ·á Àú³Î¸®ÁòÀÌ ÁÖ¿ä ºÐ¾ß·Î ¶°¿À¸£¸ç, ÀÇ·á ºÐ¾ß¿¡¼­ Á¤È®ÇÏ°í ¸Å·ÂÀûÀÎ Ä¿¹Â´ÏÄÉÀ̼ÇÀÇ Á߿伺ÀÌ ºÎ°¢µÇ¾ú½À´Ï´Ù.

3. ÃÖÁ¾»ç¿ëÀÚº° : ½ÃÀåÀº Á¦¾à ¹× ¹ÙÀÌ¿À±â¾÷°ú CRO(ÀǾàǰ °³¹ß ¼öʱâ°ü)·Î ºÐ·ùµË´Ï´Ù. 2023³â¿¡´Â Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ÀÌ Å« ºñÁßÀ» Â÷ÁöÇßÀ¸¸ç, ÀǾàǰ °³¹ß ÇÁ·Î¼¼½º Àü¹Ý¿¡ °ÉÃÄ Á¾ÇÕÀûÀÎ ¹®¼­È­°¡ ÇÊ¿äÇÏ´Ù´Â Á¡ÀÌ ¹è°æ¿¡ ÀÖ½À´Ï´Ù.

½ÃÀå Àü¸Á

±ÔÁ¦ ´ç±¹Àº ¹ÙÀÌ¿À ¹× Á¦¾à ºÐ¾ßÀÇ ½ÅÁ¦Ç°À» ½ÂÀÎÇϱâ À§ÇØ Á¦Ç° °³¹ßÀÇ ¸ðµç ´Ü°è¿¡¼­ »ç¿ëµÇ´Â ±â¹ý¿¡ ´ëÇÑ »ó¼¼ÇÑ ¹®¼­È­¸¦ ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, º¸Çè»çµµ »óȯ Á¤Ã¥À» ¼ö¸³Çϱâ À§ÇØ ÀǾàǰ¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ ¿ä±¸ÇÕ´Ï´Ù. ÀÌ ¶§¹®¿¡ Á¦¾à»ç ¹× ¹ÙÀÌ¿À Á¦¾à»çµéÀº ¾÷°è Ç¥ÁØÀ» ÁؼöÇÏ´Â °ÍÀÌ Å« °úÁ¦·Î ´ëµÎµÇ°í ÀÖ½À´Ï´Ù.

¸ÞµðÄà ¶óÀÌÅÍ´Â ÀÌ °úÁ¤¿¡¼­ ÇÁ·ÎÅäÄÝ ¼³°è¿¡ ´ëÇÑ ´Ù¾çÇÑ ¾÷¹«¿¡ Âü¿©Çϸç Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó½ÃÇè¿¡¼­ ¾òÀº µ¥ÀÌÅÍ´Â Á¦Ç° ÷ºÎ¹®¼­¿¡ Á¤È®ÇÏ°Ô ¹Ý¿µµÇ¾î¾ß Çϸç, Àü¹®¿ë¾î¸¦ ÇÇÇϰí ÀÌÇØÇϱ⠽±µµ·Ï ¿ä¾àÇØ¾ß ÇÕ´Ï´Ù. ¸ÞµðÄà ¶óÀÌÅÍ´Â ±ÔÁ¦ ¿ä°Ç¿¡ µû¶ó Á¤º¸¸¦ ó¸®ÇÏ°í ºÐ¼®ÇÏ´Â µ¥ ´É¼÷Çϸç, ¹®¼­ °³¹ß ÇÁ·Î¼¼½º¸¦ °¡¼ÓÈ­Çϰí Àüü ÀǾàǰ °³¹ß ±â°£À» ´ÜÃàÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀ» ¿øÈ°ÇÏ°Ô ¹Þ±â À§Çؼ­´Â ÀÌ·¯ÇÑ È¿À²¼ºÀÌ ÇʼöÀûÀ̱⠶§¹®¿¡ ¾÷°è¿¡¼­ ¸ÞµðÄà ¶óÀÌÆÃÀÇ Á߿伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù.

±¹°¡º° ÀλçÀÌÆ®

ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå¿¡´Â ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ°¡ Æ÷ÇԵǸç, 2023³â ¹Ì±¹ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¹Ì±¹ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù:

½ÃÀå ÁÖ¿ä ±â¾÷

ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â IQVIA, Parexel, Syneos Health, Covance µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº ½ÃÀå È®´ë¸¦ À§ÇØ Á¦ÈÞ, Çù·Â µî ´Ù¾çÇÑ Àü·«À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ParexelÀº ÀΰøÁö´É ½Ã½ºÅÛÀÇ ¼±µÎÁÖÀÚÀÎ Palantir Technologies Inc.¿Í Àü·«Àû Á¦ÈÞ¸¦ ¸Î¾î ¹ÙÀÌ¿ÀÁ¦¾à ±â¾÷ÀÇ ÀÓ»ó½ÃÇèÀÇ È¿À²¼º°ú ¾ÈÀü¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. À̹ø Á¦ÈÞ´Â PalantirÀÇ ±â¼úÀ» Ȱ¿ëÇÏ¿© ParexelÀÇ ÀÓ»ó µ¥ÀÌÅÍ Ç÷§ÆûÀ» °³¼±ÇÔÀ¸·Î½á ³ôÀº ¼öÁØÀÇ ¾ÈÀü¼º°ú ±ÔÁ¦ Áؼö¸¦ À¯ÁöÇϸ鼭 ÀÓ»ó½ÃÇè ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

±â¾÷ ¼Ò°³

ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷À¸·Î´Â Cactus Communications, Parexel International Corp, Certara Inc., Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, TransPerfect Life Sciences µîÀÌ ÀÖ½À´Ï´Ù. ÀÌµé ±â¾÷Àº »ç¾÷ È®Àå, Á¦Ç° Çõ½Å, M&A µî ´Ù¾çÇÑ Àü·«À» Ãß±¸Çϸç Á¦Ç° °­È­¿Í ½ÃÀå Á¡À¯À² È®´ë¸¦ ²ÒÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå »óȲ

Á¦5Àå ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®

Á¦7Àå ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå ºÐ¼® - À¯Çüº°

Á¦8Àå ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå ºÐ¼® - ¿ëµµº°

Á¦9Àå ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå ºÐ¼® - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ºÏ¹ÌÀÇ ¸ÞµðÄà ¶óÀÌÆÃ ½ÃÀå : ±¹°¡º° ºÐ¼®

Á¦11Àå ¾÷°è »óȲ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The North American medical writing market is projected to grow significantly, reaching an estimated US$ 3,128.66 million by 2031, up from US$ 1,333.39 million in 2023. This growth represents a compound annual growth rate (CAGR) of 11.3% from 2023 to 2031.

Executive Summary and Market Analysis

The medical writing sector in North America is primarily driven by several factors, including increasing regulatory requirements, a rise in the number of clinical trials, and the expansion of the pharmaceutical and biotechnology industries. The demand for precise medical documentation is further fueled by stringent compliance standards set by regulatory bodies such as the United States Food and Drug Administration (US FDA). Additionally, the trend of outsourcing medical writing tasks is contributing to the market's growth.

Market Segmentation Analysis

The North American medical writing market can be segmented based on type, application, and end user.

1. By Type: The market is divided into clinical writing, regulatory writing, and scientific writing. In 2023, clinical writing held the largest market share, reflecting its critical role in the documentation of clinical trials and regulatory submissions.

2. By Application: The applications of medical writing include medical journalism, medical education, and medico marketing. Medical journalism was the leading segment in 2023, highlighting the importance of accurate and engaging communication in the medical field.

3. By End User: The market is categorized into pharmaceutical and biotechnology companies and contract research organizations (CROs). In 2023, pharmaceutical and biotechnology companies accounted for a larger share of the market, driven by their need for comprehensive documentation throughout the drug development process.

Market Outlook

Regulatory authorities require detailed documentation of methodologies used during all phases of product development to approve new products in the biopharmaceutical and pharmaceutical sectors. Insurance providers also demand thorough information about drugs to establish reimbursement policies. This creates a significant challenge for pharmaceutical and biopharmaceutical companies to adhere to industry standards.

Medical writers play a vital role in this process, as they are involved in various tasks that provide insights into protocol design. The data generated from clinical trials must be accurately reflected in product labeling and summarized in a way that is understandable, avoiding technical jargon. Medical writers are adept at processing and analyzing information according to regulatory requirements, which helps expedite the document development process and, consequently, the overall drug development timeline. This efficiency is crucial for obtaining regulatory approvals smoothly, thereby increasing the importance of medical writing in the industry.

Country Insights

The North American medical writing market includes the United States, Canada, and Mexico, with the US holding the largest market share in 2023.

The growth of the US medical writing market is driven by several key factors:

Key Players in the Market

Prominent players in the North American medical writing market include IQVIA, Parexel, Syneos Health, and Covance. These companies are employing various strategies for market expansion, including partnerships and collaborations. For instance, Parexel has formed a strategic alliance with Palantir Technologies Inc., a leader in artificial intelligence systems, to enhance the efficiency and safety of clinical trials for biopharmaceutical clients. This collaboration aims to leverage Palantir's technology to improve Parexel's clinical data platform, thereby streamlining the clinical trial process while maintaining high standards of safety and regulatory compliance.

Company Profiles

Key companies operating in the North American medical writing market include Cactus Communications, Parexel International Corp, Certara Inc., Freyr LLC, Quanticate International Ltd, SIRO Clinpharm Pvt Ltd, ProPharma Group, Caidya, Wipro Ltd, SGS SA, Laboratory Corp of America Holdings, TUNECT, Indegene Ltd, Evidera, Syner-G BioPharma Group, EMTEX BV, BioAgile Therapeutics Private Limited, Tata Consultancy Services Ltd, InClin, and TransPerfect Life Sciences. These companies are pursuing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase their market share.

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. North America Medical Writing Market Landscape

5. North America Medical Writing Market - Key Market Dynamics

6. Medical Writing Market - North America Market Analysis

7. North America Medical Writing Market Analysis - by Type

8. North America Medical Writing Market Analysis - by Application

9. North America Medical Writing Market Analysis - by End User

10. North America Medical Writing Market - Country Analysis

11. Industry Landscape

12. Company Profiles

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â